Souhaitez-vous accéder aux communiqués récents ?

WASHINGTON, D.C., May 06, 2026 (GLOBE NEWSWIRE) -- The Support Is Care Summit brought people living with cancer, caregivers, and providers from across the country to Washington, D.C., to advocate...

Brad Saar joins Sonablate board to support growth of non-invasive prostate cancer treatment to signal next phase of expansion for HIFU-based prostate care.

With AI tools demonstrating 85–95% accuracy in biomarker identification and attracting more than $3 billion in recent funding.

Tovecimig Demonstrates Significant Benefit in Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer

Providence Saint John’s announced the largest philanthropic gift in its history, an estate gift estimated at $100 million from the late Stan Lucas.

Radioligand Therapeutics Market in Cancer Treatment to Reach $4.8 Billion by 2030, Reports BCC Research

Messino Cancer Centers Opens New Asheville Clinic

Conventional chemo hits walls of resistance, brutal toxicity, and minimal progress. PRP changes the game.

The purpose of the study will be used as an important tool to measure the concentration of PRP and its analytes over time upon administration to patients

Preclinical data shines: >85% tumor growth inhibition in pancreatic models, reduced fibrosis and resistance markers, and a gentler safety profile